ZyVersa Therapeutics Inc (ZVSA) concluded trading on Wednesday at a closing price of $0.94, with 5.97 million shares of worth about $5.62 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -65.79% during that period and on March 05, 2025 the price saw a loss of about -12.58%. Currently the company’s common shares owned by public are about 2.51M shares, out of which, 2.50M shares are available for trading.
Stock saw a price change of -19.99% in past 5 days and over the past one month there was a price change of -30.58%. Year-to-date (YTD), ZVSA shares are showing a performance of -10.93% which decreased to -90.92% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $0.98 but also hit the highest price of $10.80 during that period. The average intraday trading volume for ZyVersa Therapeutics Inc shares is 789.48K. The stock is currently trading -20.39% below its 20-day simple moving average (SMA20), while that difference is down -24.84% for SMA50 and it goes to -61.75% lower than SMA200.
ZyVersa Therapeutics Inc (NASDAQ: ZVSA) currently have 2.51M outstanding shares and institutions hold larger chunk of about 3.23% of that.
The stock has a current market capitalization of $2.37M and its 3Y-monthly beta is at 0.42. It has posted earnings per share of -$43.19 in the same period. It has Quick Ratio of 0.03 while making debt-to-equity ratio of 0.00. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for ZVSA, volatility over the week remained 8.63% while standing at 8.06% over the month.
